CELLDEX THERAPEUTICS INC NEW's ticker is and the CUSIP is 15117B952. A total of 5 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $288,960 | -36.4% | 10,500 | -21.6% | 0.00% | – |
| Q2 2023 | $454,662 | -87.9% | 13,400 | -84.1% | 0.00% | -100.0% |
| Q4 2022 | $3,761,708 | +57.5% | 84,400 | -0.7% | 0.00% | +100.0% |
| Q3 2022 | $2,389,000 | -55.9% | 85,000 | -57.7% | 0.00% | -50.0% |
| Q2 2022 | $5,416,000 | – | 200,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PURA VIDA INVESTMENTS, LLC | 100,000 | $2,696,000 | 0.16% |
| GROUP ONE TRADING, L.P. | 93,900 | $2,532,000 | 0.00% |
| SIMPLEX TRADING, LLC | 87,400 | $2,356,000 | 0.00% |
| JANE STREET GROUP, LLC | 200,900 | $5,416,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |